IGNE Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$17.22M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,565,404,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IGNE FAQ
What was IGENE Biotechnology Inc’s price range in the past 12 months?
IGENE Biotechnology Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is IGENE Biotechnology Inc’s market cap?
IGENE Biotechnology Inc’s market cap is $17.22M.
When is IGENE Biotechnology Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IGENE Biotechnology Inc’s earnings last quarter?
Currently, no data Available
Is IGENE Biotechnology Inc overvalued?
According to Wall Street analysts IGENE Biotechnology Inc’s price is currently Overvalued.
Does IGENE Biotechnology Inc pay dividends?
IGENE Biotechnology Inc does not currently pay dividends.
What is IGENE Biotechnology Inc’s EPS estimate?
IGENE Biotechnology Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IGENE Biotechnology Inc have?
IGENE Biotechnology Inc has 1,565,404,300 shares outstanding.
What happened to IGENE Biotechnology Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IGENE Biotechnology Inc?
Currently, no hedge funds are holding shares in IGNE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IGENE Biotechnology Inc
Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Technical Analysis
Origin Agritech
―
Arcadia Biosciences
―
BioHarvest Sciences
―
Bioceres Crop Solutions
―
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.47% Other Institutional Investors
99.53% Public Companies and
Individual Investors